Stock 002020 ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Zhejiang Jingxin Pharmaceutical Co., Ltd.

Equities

002020

CNE000001K73

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
11.41 CNY +0.44% Intraday chart for Zhejiang Jingxin Pharmaceutical Co., Ltd. +13.08% -10.30%
Apr. 23 Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Jingxin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Evotec Says Partner Obtained Regulatory Approval in China for Insomnia Drug
Aktien Frankfurt Eröffnung: Dax weiter auf Rekordkurs - Merck-Kursrutsch
Evotec-Partner Jingxin erhält Zulassung für EVT201 in China
Aktien Frankfurt Ausblick: Dax weiter auf Rekordjagd - Merck KGaA brechen ein
Jingxin Pharmaceutical Gets Nod to Market Didacinil Capsules
Evotec-Partner erhält Zulassung in China für Mittel gegen Schlafstörungen
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jingxin Pharma's Unit Gets Nod to Market Eye Drug in Europe
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan, Payable on 24 May 2023
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Jingxin Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022
Zhejiang Jingxin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Directorate Appointments
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002020 Stock
  4. News Zhejiang Jingxin Pharmaceutical Co., Ltd.
  5. Other languages